Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3202-3209

  Tegos, George P ^a,b   Masago, Kayo ^a,c   Aziz, Fatima ^a,d   Higginbotham, Andrew ^e   Stermitz, Frank R ^e   Hamblin, Michael R ^a,b,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^e Department of Environmental and Radiological Health Sciences   (United States)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' METHOXYHYDNOCARPIN; ADH7; AMIDE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; DIMETHYLENE BLUE; DYE; INF 271; METHYLENE BLUE; NORA PROTEIN; PHENYLALANINE ARGININE BETA NAPHTHYLAMIDE; PHOTOSENSITIZING AGENT; PROTEIN DERIVATIVE; RESERPINE; SODIUM CHLORIDE; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; NODULATION; NONHUMAN; NULL CELL; PHOTODYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RED LIGHT; STAPHYLOCOCCUS AUREUS;

BACTERIAL PROTEINS; CARBANILIDES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; FLAVONOIDS; LIGHT; METHYLENE BLUE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHENOTHIAZINES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TOLONIUM CHLORIDE;

EID: 50949103059     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00006-08     Document Type: Article

References (39)

1. Ahmed, M., C. M. Borsch, A. A. Neyfakh, and S. Schuldiner. 1993. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J. Biol. Chem. 268:11086-11089.
2. Bhatti, M., A. MacRobert, S. Meghji, B. Henderson, and M. Wilson. 1998. A study of the uptake of toluidine blue O by Porphyromonas gingivalis and the mechanism of lethal photosensitization. Photochem. Photobiol. 68:370-376.
3. Bressler, N. M., and S. B. Bressler. 2000. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. Investig. Ophthalmol. Vis. Sci. 41:624-628.
4. Castano, A. P., T. N. Demidova, and M. R. Hamblin. 2004. Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 1:279-293.
5. Demidova, T. N., and M. R. Hamblin. 2005. Photodynamic inactivation of bacillus spores, mediated by phenothiazinium dyes. Appl. Environ. Microbiol. 71:6918-6925.
6. Dolmans, D. E., D. Fukumura, and R. K. Jain. 2003. Photodynamic therapy for cancer. Nat. Rev. Cancer 3:380-387.
7. Gad, F., T. Zahra, T. Hasan, and M. R. Hamblin. 2004. Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob. Agents Chemother. 48:2173-2178.
8. Gibbons, S., and E. E. Udo. 2000. The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant. Phytother. Res. 14:139-140.
9. Hamblin, M. R., and T. Hasan. 2004. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3:436-450.
10. Jett, B. D., K. L. Hatter, M. M. Huycke, and M. S. Gilmore. 1997. Simplified agar plate method for quantifying viable bacteria. BioTechniques 23:648-650.
11. Kaatz, G. W., S. M. Seo, L. O'Brien, M. Wahiduzzaman, and T. J. Foster. 2000. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob. Agents Chemother. 44:1404-1406.
12. Lewis, K. 1999. Versatile drug sensors of bacterial cells. Curr. Biol. 9:403-407.
13. Lewis, K., and F. M. Ausubel. 2006. Prospects for plant-derived antibacterials. Nat. Biotechnol. 24:1504-1507.
14. Li, X. Z., L. Zhang, R. Srikumar, and K. Poole. 1998. Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:399-403.
15. Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
16. Lynch, A. S. 2006. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view. Biochem. Pharmacol. 71:949-956.
17. Malik, Z., H. Ladan, and Y. Nitzan. 1992. Photodynamic inactivation of Gram-negative bacteria: problems and possible solutions. J. Photochem. Photobiol. B 14:262-266.
18. Markham, P. N., E. Westhaus, K. Klyachko, M. E. Johnson, and A. A. Neyfakh. 1999. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:2404-2408.
19. Moan, J., and Q. Peng. 2003. An outline of the hundred-year history of PDT. Anticancer Res. 23:3591-3600.
20. Neyfakh, A. A. 1992. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob. Agents Chemother. 36:484-485.
21. Neyfakh, A. A., C. M. Borsch, and G. W. Kaatz. 1993. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother. 37:128-129.
22. Nitzan, Y., M. Gutterman, Z. Malik, and B. Ehrenberg. 1992. Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem. Photobiol. 55:89-96.
23. Norton, S. A. 1994. Useful plants of dermatology. I. Hydnocarpus and chaulmoogra. J. Am. Acad. Dermatol. 31:683-686.
24. O'Neill, J., M. Wilson, and M. Wainwright. 2003. Comparative antistreptococcal activity of photobactericidal agents. J. Chemother. 15:329-334.
25. Phoenix, D. A., Z. Sayed, S. Hussain, F. Harris, and M. Wainwright. 2003. The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 39:17-22.
26. Poole, K. 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51.
27. Romanova, N. A., L. Y. Brovko, L. Moore, E. Pometun, A. P. Savitsky, N. N. Ugarova, and M. W. Griffiths. 2003. Assessment of photodynamic destruction of Escherichia coli O157:H7 and Listeria monocytogenes by using ATP bioluminescence. Appl. Environ. Microbiol. 69:6393-6398.
28. Stermitz, F. R., K. K. Cashman, K. M. Halligan, C. Morel, G. P. Tegos, and K. Lewis. 2003. Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors. Bioorg. Med. Chem. Lett. 13:1915-1918.
29. Stermitz, F. R., P. Lorenz, J. N. Tawara, L. A. Zenewicz, and K. Lewis. 2000. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. USA 97:1433-1437.
30. Stermitz, F. R., J. Tawara-Matsuda, P. Lorenz, P. Mueller, L. Zenewicz, and K. Lewis. 2000. 5′-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus. J. Nat. Prod. 63:1146-1149.
31. Tegos, G., F. R. Stermitz, O. Lomovskaya, and K. Lewis. 2002. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 46:3133-3141.
32. Tegos, G. P. 2006. Natural substrates and inhibitors of multidrug resistant pumps (MDRs) redefine the plant antimicrobials. In C. Carpinella and M. Rai (ed.), Naturally occurring bioactive compounds: a new and safe alternative for control of pests and microbial diseases. Cambridge University Press, Cambridge, United Kingdom.
33. Tegos, G. P., and M. R. Hamblin. 2006. Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob. Agents Chemother. 50:196-203.
34. Truong-Bolduc, Q. C., and D. C. Hooper. 2007. The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus. J. Bacteriol. 189:2996-3005.
35. Truong-Bolduc, Q. C., X. Zhang, and D. C. Hooper. 2003. Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J. Bacteriol. 185:3127-3138.
36. Wainwright, M. 2003. The use of dyes in modern biomedicine. Biotech. Histochem. 78:147-155.
37. Wainwright, M., D. A. Phoenix, S. L. Laycock, D. R. Wareing, and P. A. Wright. 1998. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol. Lett. 160:177-181.
38. Wainwright, M., D. A. Phoenix, J. Marland, D. R. Wareing, and F. J. Bolton. 1997. A study of photobactericidal activity in the phenothiazinium series. FEMS Immunol. Med. Microbiol. 19:75-80.
39. Wong, T. W., Y. Y. Wang, H. M. Sheu, and Y. C. Chuang. 2005. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob. Agents Chemother. 49:895-902.